Growing community of inventors

Kamakura, Japan

Akira Myomoto

Average Co-Inventor Count = 7.78

ph-index = 2

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 4

Akira MyomotoSatoko Kozono (4 patents)Akira MyomotoHitoshi Nobumasa (3 patents)Akira MyomotoYoshinori Tanaka (2 patents)Akira MyomotoOsamu Ogawa (40 patents)Akira MyomotoGozoh Tsujimoto (4 patents)Akira MyomotoHideo Akiyama (3 patents)Akira MyomotoYutaka Shimada (3 patents)Akira MyomotoOsamu Nomura (2 patents)Akira MyomotoShiori Tomoda (2 patents)Akira MyomotoFumiaki Sato (1 patent)Akira MyomotoKazuharu Shimizu (1 patent)Akira MyomotoMasakazu Toi (1 patent)Akira MyomotoTakayuki Ueno (1 patent)Akira MyomotoZhipeng Wang (1 patent)Akira MyomotoEijiro Nakamura (0 patent)Akira MyomotoZhipeng Wang (0 patent)Akira MyomotoAkira Myomoto (4 patents)Satoko KozonoSatoko Kozono (52 patents)Hitoshi NobumasaHitoshi Nobumasa (54 patents)Yoshinori TanakaYoshinori Tanaka (48 patents)Osamu OgawaOsamu Ogawa (40 patents)Gozoh TsujimotoGozoh Tsujimoto (6 patents)Hideo AkiyamaHideo Akiyama (6 patents)Yutaka ShimadaYutaka Shimada (3 patents)Osamu NomuraOsamu Nomura (40 patents)Shiori TomodaShiori Tomoda (2 patents)Fumiaki SatoFumiaki Sato (10 patents)Kazuharu ShimizuKazuharu Shimizu (10 patents)Masakazu ToiMasakazu Toi (6 patents)Takayuki UenoTakayuki Ueno (3 patents)Zhipeng WangZhipeng Wang (1 patent)Eijiro NakamuraEijiro Nakamura (0 patent)Zhipeng WangZhipeng Wang (0 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Toray Industries, Inc. (4 from 3,481 patents)

2. Kyoto University (4 from 820 patents)


4 patents:

1. 9873916 - Method for predicting response to trastuzumab therapy in breast cancer patients

2. 8945849 - Method for diagnosing esophageal cancer

3. 8198025 - Method for diagnosing esophageal cancer

4. 7932032 - Method for diagnosing esophageal cancer

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
1/6/2026
Loading…